2020
DOI: 10.1128/mbio.00760-20
|View full text |Cite
|
Sign up to set email alerts
|

Novel Immunoglobulin Domain Proteins Provide Insights into Evolution and Pathogenesis of SARS-CoV-2-Related Viruses

Abstract: A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was recently identified as the causative agent for the coronavirus disease 2019 (COVID-19) outbreak that has generated a global health crisis. We use a combination of genomic analysis and sensitive profile-based sequence and structure analysis to understand the potential pathogenesis determinants of this virus. As a result, we identify several fast-evolving genomic regions that might be at the interface of virus-host interaction… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
108
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(116 citation statements)
references
References 66 publications
7
108
1
Order By: Relevance
“…The SARS-CoV-2 orf7a is a transmembrane protein of 121 amino acids (106 if only the mature protein is considered, excluding the signaling peptide), with 86% identity and 94% similarity with respect to its SARS-CoV counterpart. Interestingly, it exhibits structural similarity to Igs ( Nelson et al, 2005 ; Tan et al, 2020 ), but shares poor sequence identity with proteins of the Ig superfamily (within the 2–16% range). Like orf3a, orf7a is also included in the virion, and both proteins have been shown to interact with each other in SARS-CoV ( Tan et al, 2004 ) and in SARS-CoV-2 ( Li et al, 2020a ).…”
Section: Druggability Characterization Of Sars-cov-2 Proteinsmentioning
confidence: 99%
See 1 more Smart Citation
“…The SARS-CoV-2 orf7a is a transmembrane protein of 121 amino acids (106 if only the mature protein is considered, excluding the signaling peptide), with 86% identity and 94% similarity with respect to its SARS-CoV counterpart. Interestingly, it exhibits structural similarity to Igs ( Nelson et al, 2005 ; Tan et al, 2020 ), but shares poor sequence identity with proteins of the Ig superfamily (within the 2–16% range). Like orf3a, orf7a is also included in the virion, and both proteins have been shown to interact with each other in SARS-CoV ( Tan et al, 2004 ) and in SARS-CoV-2 ( Li et al, 2020a ).…”
Section: Druggability Characterization Of Sars-cov-2 Proteinsmentioning
confidence: 99%
“…Orf8 is one of the fastest evolving genes in SARS-CoV-2, as can be inferred by its high variability ( Tan et al, 2020 ). The orf8 expression is not essential for SARS-CoV and SARS-CoV-2 replication; it was observed, however, that a 29 nucleotide deletion in SARS-CoV may correlate with milder disease ( Muth et al, 2018 ).…”
Section: Druggability Characterization Of Sars-cov-2 Proteinsmentioning
confidence: 99%
“…Among these accessory proteins, ORF8 is a significantly exclusive protein as it is different from another known SARS-CoV and thus associated with high efficiency in pathogenicity transmission [11,12]. The SARS-CoV-2 ORF8 displays arrays of functions; inhibition of interferon 1, promoting viral replication, inducing apoptosis and modulating ER stress [13,14,15].…”
Section: Introductionmentioning
confidence: 99%
“…A 382 nucleotide deletion (Δ382) in SARS-CoV-2 (9,10) was also found to correlate with milder disease and a lower incidence of hypoxia (11). SARS-CoV-2 ORF8 is a 121 amino acid protein consisting of an N-terminal signal sequence followed by a predicted Ig-like fold (12). With <20% sequence identity to SARS-CoV ORF8, SARS-CoV-2 ORF8 is remarkably divergent.…”
mentioning
confidence: 99%
“…These observations show how recent evolutionary changes in the sequence of SARS-CoV-2 relative to its more benign precursors could contribute to a unique higher-order assembly mediating unique functions in immune evasion and suppression. (12). Asterisks designate residues contributing to the 'covalent' dimer interface.…”
mentioning
confidence: 99%